Skip to main content
. 2018 Oct 30;16:462–478. doi: 10.1016/j.csbj.2018.10.016

Fig. 3.

Fig. 3

Relationship between activity and concentration of Afatinib and selected compound 14d and 19b against four cancer cell lines.